Disproportionality analysis of adverse reaction signals related to Inclisiran based on FDA Adverse Event Reporting System database

doi:10.3969/j.issn.1672-3384.2024.11.015

Xiaoli JIA, Hongyan WANG, Ruiling LIU, Xiaoyan XU, Qiling CHEN

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (11) : 79-83.

PDF(450 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (11) : 79-83. DOI: 10.3969/j.issn.1672-3384.2024.11.015

Original Article

Disproportionality analysis of adverse reaction signals related to Inclisiran based on FDA Adverse Event Reporting System database

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(11): 79-83 https://doi.org/10.3969/j.issn.1672-3384.2024.11.015

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(450 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2024-06-21	2024-11-20
Issue Date
2025-01-20

Please choose a citation manager

Content to export